Eric Dobmeier

Biography

 Eric Dobmeier is Chief Operating Officer of Seattle Genetics. He oversees the company's business development, corporate communications, manufacturing and program/alliance management groups, as well as corporate strategy initiatives. While at Seattle Genetics he has led negotiation and completion of multiple corporate alliances, including the ex-U.S./Canada development and commercialization agreement with Takeda Pharmaceutical Company for ADCETRIS® and ten ADC collaborations with leading biotechnology and pharmaceutical companies. He has also been directly involved in raising more than $1.2 billion in capital for Seattle Genetics. Prior to joining the company, Mr. Dobmeier was with the law firms of Venture Law Group and Heller Ehrman LLP where he represented technology companies in connection with public and private financings, mergers and acquisitions and corporate partnering transactions.

Research Interest

 Oncology